Clinical Trials Browser

OTHER × Pancreatic Neoplasms × Cyclooxygenase 2 Inhibitors × Clear all

NCT01111591 2016-10-28

Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas Cancer

Phase 4 Unknown

Gastrointestinal

Bile Duct Neoplasms, Pancreatic Neoplasms

NCT00198081 2016-02-29

Use of Celecoxib in Patients With Intraductal Papillary Mucinous Neoplasms (IPMNs)

Phase 2 Terminated

8 enrolled 11 charts

Gastrointestinal

Pancreatic Neoplasms